{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:56:04Z","timestamp":1787028964454,"version":"build-2736575974"},"reference-count":34,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Including Chronic Myeloid Leukemia (CML) patients with deep molecular responses (MR4.5) and those with suboptimal responses provides valuable insights into treatment-associated metabolic changes. This study aimed to characterize the metabolomic alterations associated with CML and identify potential biomarkers for treatment response, particularly in patients achieving a deeper molecular response versus those with poorer responses. Methods: Plasma samples were collected from 51 chronic-phase CML patients and 24 healthy controls. CML patients were classified into two groups based on molecular responses: T1 (BCR-ABL1 IS \u2264 0.0032%) and T2 (BCR-ABL1 IS &gt; 0.0032%, &lt;1%). Metabolomic profiling was conducted using quadrupole time-of-flight liquid chromatography\/mass spectrometry. The data analysis involved a partial least squares discriminant analysis, variable importance in projection (VIP) scores, and a pathway enrichment analysis. Significant metabolites were identified. Results: The PLS-DA revealed distinct metabolomic profiles between CML patients and healthy controls as well as between the T1 and T2 groups. Key differentiating metabolites with VIP scores &gt; 1.5 included glutamate, hypoxanthine, and D-galactonic acid. In the T2 group, significant increases in malate and 5-aminoimidazole-4-carboxamide ribonucleotide were observed, reflecting disruptions in purine metabolism, the tricarboxylic acid cycle, and amino acid metabolism. The pathway enrichment analysis highlighted significant alterations in CML energy metabolism, nucleotide synthesis, and amino acid biosynthesis. Conclusions: CML patients exhibit pronounced metabolic changes, particularly in energy and nucleotide metabolism, which are linked to treatment response. These findings provide novel insights into CML biology and suggest potential biomarkers for monitoring treatment efficacy and predicting outcomes and therapeutic targets for improving treatment outcomes and overcoming tyrosine kinase inhibitor resistance.<\/jats:p>","DOI":"10.3390\/metabo15060376","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T06:11:08Z","timestamp":1749190268000},"page":"376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metabolomic Profiling and Bioanalysis of Chronic Myeloid Leukemia: Identifying Biomarkers for Treatment Response and Disease Monitoring"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7197-6890","authenticated-orcid":false,"given":"Selim","family":"Say\u0131n","sequence":"first","affiliation":[{"name":"Department of Hematology, G\u00fclhane Training and Research Hospital, Ankara 06010, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6416-9575","authenticated-orcid":false,"given":"Murat","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[{"name":"Department of Hematology, G\u00fclhane Training and Research Hospital, Ankara 06010, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8968-3917","authenticated-orcid":false,"given":"Batuhan","family":"Erdo\u011fdu","sequence":"additional","affiliation":[{"name":"Department of Hematology, G\u00fclhane Training and Research Hospital, Ankara 06010, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara 06230, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Ko\u00e7","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara 06230, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Bulduk","sequence":"additional","affiliation":[{"name":"Department of Hematology, G\u00fclhane Training and Research Hospital, Ankara 06010, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melda","family":"C\u00f6mert","sequence":"additional","affiliation":[{"name":"Department of Hematology, G\u00fclhane Training and Research Hospital, Ankara 06010, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"G\u00fcney","sequence":"additional","affiliation":[{"name":"Blood Center, G\u00fclhane Training and Research Hospital, Ankara 06010, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-5512","authenticated-orcid":false,"given":"Mustafa","family":"\u00c7elebier","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara 06230, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5766-5642","authenticated-orcid":false,"given":"Meltem","family":"Ayl\u0131","sequence":"additional","affiliation":[{"name":"Department of Hematology, G\u00fclhane Training and Research Hospital, Ankara 06010, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"ref_1","first-page":"85","article-title":"Chromosome Studies on Normal and Leukemic Human Leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/leu.2017.63","article-title":"Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the ENESTfreedom study","volume":"31","author":"Hochhaus","year":"2017","journal-title":"Leukemia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrm3772","article-title":"Metabolic requirements for the maintenance of self-renewing stem cells","volume":"15","author":"Ito","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_6","first-page":"2","article-title":"Applications of metabolomics to study cancer metabolism","volume":"1870","author":"Kaushik","year":"2018","journal-title":"Biochim. Biophys. Acta BBA Bioenerg."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Song, B.H., Son, S.Y., Kim, H.K., Ha, T.W., Im, J.S., Ryu, A., Jeon, H., Chung, H.Y., Oh, J.S., and Lee, C.H. (2020). Profiling of metabolic differences between hematopoietic stem cells and acute\/chronic myeloid leukemia. Metabolites, 10.","DOI":"10.3390\/metabo10110427"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the Origin of Cancer Cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12288-019-01107-8","article-title":"The Metabolic Profiles in Hematological Malignancies","volume":"35","author":"Liu","year":"2019","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.18632\/oncotarget.6426","article-title":"Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth","volume":"7","author":"Polet","year":"2016","journal-title":"Oncotarget"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","article-title":"Glutaminolysis: A Hallmark of Cancer Metabolism","volume":"19","author":"Yang","year":"2017","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_12","first-page":"3521","article-title":"Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia","volume":"122","author":"Willems","year":"2013","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1634\/theoncologist.2009-0297","article-title":"Why doesn\u2019t imatinib cure chronic myeloid leukemia?","volume":"15","author":"Redner","year":"2010","journal-title":"Oncologist"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"de Almeida, F.C., Berzoti-Coelho, M.G., Toro, D.M., Cacemiro, M.d.C., Bassan, V.L., Barretto, G.D., Garibaldi, P.M.M., Palma, L.C., de Figueiredo-Pontes, L.L., and Sorgi, C.A. (2022). Bioactive lipids as chronic myeloid leukemia\u2019s potential biomarkers for disease progression and response to tyrosine kinase inhibitors. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.840173"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.18632\/oncotarget.2869","article-title":"Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells","volume":"6","author":"Song","year":"2015","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-04-0039","article-title":"Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells","volume":"10","author":"Gottschalk","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A., and Ore\u0161i\u010d, M. (2010). MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform., 11.","DOI":"10.1186\/1471-2105-11-395"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lu, Y., Pang, Z., and Xia, J. (2023). Comprehensive investigation of pathway enrichment methods for functional interpretation of LC\u2013MS global metabolomics data. Briefings Bioinform., 24.","DOI":"10.1093\/bib\/bbac553"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00006676-200201000-00004","article-title":"A metabolic hypothesis of cell growth and death in pancreatic cancer","volume":"24","author":"Boros","year":"2002","journal-title":"Pancreas"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101410","DOI":"10.1016\/j.molmet.2021.101410","article-title":"Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells","volume":"55","author":"Trinh","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_22","first-page":"1639","article-title":"Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition","volume":"131","author":"Gallipoli","year":"2018","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","article-title":"Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells","volume":"23","author":"Kuntz","year":"2017","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41419-022-04842-5","article-title":"Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells","volume":"13","author":"Yan","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20131738","article-title":"Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication","volume":"211","author":"Nathanson","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-15-0068","article-title":"Dissecting the dual role of AMPK in cancer: From experimental to human studies","volume":"13","author":"Zadra","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: Glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/pr400403p","article-title":"Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis","volume":"12","author":"Wang","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exphem.2017.09.007","article-title":"Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia","volume":"58","author":"Gregory","year":"2018","journal-title":"Exp. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","article-title":"Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells","volume":"1807","author":"Pike","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation\u2014A novel therapeutic intervention in the ischemic and failing heart","volume":"1813","author":"Jaswal","year":"2011","journal-title":"Biochim. et Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI38942","article-title":"Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction","volume":"120","author":"Samudio","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/cas.13500","article-title":"Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients","volume":"109","author":"Yang","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/6\/376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:47:30Z","timestamp":1760032050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/15\/6\/376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["metabo15060376"],"URL":"https:\/\/doi.org\/10.3390\/metabo15060376","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}